Engages Thrive Health, a Leading Digital Patient Care Platform to Streamline Care Programs and Data CollectionOAKVILLE, ON / ACCESSWIRE / April 21, 2022 / NeonMind Biosciences Inc. (CSE:NEON)(OTCQB:NMDBD)(FRA:6UF)
: NeonMind Biosciences Inc. (CSE: NEON) (OTCQB: NMDBF) (FRA: 6UF) (“NeonMind or the “Company”), announced today it has advanced its strategy to streamline
NeonMind to Improve Patient Care and Data Management by Adopting Digital Platform for Ketamine Treatments einnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from einnews.com Daily Mail and Mail on Sunday newspapers.